Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Total Assets (Quarterly) : 101.08M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 101.08M |
| March 31, 2026 | 109.63M |
| December 31, 2025 | 119.59M |
| September 30, 2025 | 137.01M |
| June 30, 2025 | 178.06M |
| March 31, 2025 | 165.21M |
| December 31, 2024 | 214.52M |
| September 30, 2024 | 264.42M |
| June 30, 2024 | 293.20M |
| March 31, 2024 | 365.87M |
| December 31, 2023 | 423.53M |
| September 30, 2023 | 460.43M |
| June 30, 2023 | 515.13M |
| March 31, 2023 | 538.54M |
| December 31, 2022 | 610.09M |
| September 30, 2022 | 608.84M |
| June 30, 2022 | 686.79M |
| March 31, 2022 | 745.93M |
| December 31, 2021 | 773.82M |
| September 30, 2021 | 850.51M |
| June 30, 2021 | 808.62M |
| March 31, 2021 | 787.30M |
| December 31, 2020 | 826.84M |
| September 30, 2020 | 812.02M |
| June 30, 2020 | 807.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 824.38M |
| December 31, 2019 | 857.40M |
| September 30, 2019 | 893.96M |
| June 30, 2019 | 915.07M |
| March 31, 2019 | 812.40M |
| December 31, 2018 | 880.60M |
| September 30, 2018 | 855.64M |
| June 30, 2018 | 869.92M |
| March 31, 2018 | 867.61M |
| December 31, 2017 | 898.65M |
| September 30, 2017 | 894.89M |
| June 30, 2017 | 542.64M |
| March 31, 2017 | 441.76M |
| December 31, 2016 | 469.55M |
| September 30, 2016 | 486.21M |
| June 30, 2016 | 499.13M |
| March 31, 2016 | 442.54M |
| December 31, 2015 | 470.57M |
| September 30, 2015 | 499.25M |
| June 30, 2015 | 541.40M |
| March 31, 2015 | 435.54M |
| December 31, 2014 | 483.53M |
| September 30, 2014 | 344.38M |
| June 30, 2014 | 372.66M |
| March 31, 2014 | 282.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vericel Corp. | 502.87M |
| Capricor Therapeutics, Inc. | 368.74M |
| ARS Pharmaceuticals, Inc. | 249.50M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 109.22M |
| Shareholders Equity (Quarterly) | -30.14M |
| Current Ratio | 2.687 |
| Net Debt Paydown Yield | 59.68% |